Skip to Content

BMS 1611 (Baraclude 0.5 mg)

Generic Name: entecavir

Pill with imprint BMS 1611 is White, Three-sided and has been identified as Baraclude 0.5 mg. It is supplied by Bristol-Myers Squibb.

Baraclude is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Baraclude 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 1611

Baraclude

Generic Name
entecavir
Imprint
BMS 1611
Strength
0.5 mg
Color
White
Size
8.00 mm
Shape
Three-sided
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb
Inactive Ingredients
lactose monohydrate, microcrystalline cellulose, povidone, magnesium stearate, titanium dioxide, hypromelloses, polyethylene glycol 400, polysorbate 80

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00003-1611
49884-0104 Par Pharmaceutical, Inc.

Get help with Imprint Code FAQs.

Related Images for "BMS 1611"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.